Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amylyx Pharmaceuticals
Marketing
Amylyx names exec to lead GLP-1 receptor antagonist launch
Amylyx Pharmaceuticals has named Dan Monahan, who previously led U.S. commercialization of Otsuka's Rexulti, to be its chief commercial officer.
Nick Paul Taylor
Jan 6, 2025 10:40am
A revival in neuro therapeutics
Oct 11, 2024 8:37am
Amylyx to pull failed ALS drug from market, cut 70% of staff
Apr 4, 2024 10:06am
Amylyx's ALS drug Albrioza rebuffed by EU regulator—again
Oct 13, 2023 11:24am
Amylyx's ALS drug Relyvrio continues to shine
Aug 11, 2023 11:32am
Biogen pays $7.3B to acquire Reata and newly approved Skyclarys
Jul 28, 2023 11:17am
